CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer’s Disease—A Narrative Review

Alzheimer’s disease (AD) is a chronic and irreversible neurodegenerative disorder characterized by cognitive deficiency and development of amyloid-β (Aβ) plaques and neurofibrillary tangles, comprising hyperphosphorylated tau. The number of patients with AD is alarmingly increasing worldwide; curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Barman, Nirmal Chandra, Khan, Niuz Morshed, Islam, Maidul, Nain, Zulkar, Roy, Rajib Kanti, Haque, Anwarul, Barman, Shital Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606404/
https://www.ncbi.nlm.nih.gov/pubmed/33089409
http://dx.doi.org/10.1007/s40120-020-00218-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606404/
https://www.ncbi.nlm.nih.gov/pubmed/33089409
http://dx.doi.org/10.1007/s40120-020-00218-z

Ejemplares similares